市场调查报告书
商品编码
1395748
机械人工呼吸器全球市场规模、占有率、行业趋势分析报告:按模式、按组件、按产品类型、按年龄组、按最终用户、按地区、展望和预测,2023-2030 年Global Mechanical Ventilators Market Size, Share & Industry Trends Analysis Report By Mode, By Component, By Product Type, By Age Group (Adult, Geriatric, and Pediatric & Neonatal), By End User, By Regional Outlook and Forecast, 2023 - 2030 |
预计到 2030 年,机械人工呼吸器市场规模将达到 167 亿美元,预测期内复合年增长率为 12.6%。 2022年市场规模为103.94万台,成长率为27.4%(2019-2022年)。
根据 KBV Cardinal 矩阵中的分析,美敦力 PLC 是市场先驱。例如,2022 年 4 月,美敦力 (Medtronic) PLC 与 GE Healthcare 合作,专注于门诊手术中心 (ASC) 和办公室实验室 (OBL) 的独特护理需求和需求。这种合作关係为客户提供了广泛的产品系列、金融解决方案和卓越的服务。通用电气 (GE)、Koninklijke Philips NV 和 Dragerwerk AG &Co.KGaA 等公司是市场上的主要创新者。
COVID-19 影响分析
COVID-19 对市场最直接、最明显的影响是对这些救生设备的需求空前激增。随着病毒迅速传播并使各国医疗保健系统不堪重负,支持重症患者的人工呼吸器严重短缺。医院和医疗机构必须增加人工呼吸器容量,以应对涌入的 COVID-19 患者。 COVID-19 加速了远端监控和远端医疗解决方案的采用,包括将人工呼吸器整合到远端医疗网路中。儘管这些设计缺乏传统人工呼吸器的一些先进功能,但它们专注于满足需求激增的基本功能。虽然这些创新提供了短期缓解,但它们也引发了人们对快速开发的设备的品质和安全性的担忧。因此,COVID-19大流行对市场产生了正面影响。
市场成长要素
呼吸道疾病盛行率上升
慢性阻塞性肺病、气喘和间质性肺病等呼吸系统疾病在高龄化族群中尤其常见。这些疾病往往需要长期或间歇性的机械通气支持,产生了对机械人工呼吸器的持续需求。心臟衰竭和神经肌肉疾病等多种慢性疾病可能导致呼吸系统併发症,需要机械通气才能达到最佳的患者护理。这些疾病的同时发生增加了对人工呼吸器的需求。呼吸窘迫症候群和支气管炎等儿童和新生儿呼吸系统疾病的流行需要专门的新生儿和儿童用人工呼吸器。呼吸系统疾病的流行正在推动机械人工呼吸器与远端医疗网路和远端监控技术的整合。这将使医疗保健提供者能够远端监测患有呼吸道疾病的患者并调整人工呼吸器设置,从而改善获得护理的机会。呼吸道疾病盛行率上升是市场成长的关键因素。
扩大家庭通风计划
家庭通风计画正在增加家庭环境中对机械人工呼吸器的需求。这些人工呼吸器紧凑、易于使用,而且通常易于操作,适合患者和看护者。患有慢性呼吸系统疾病(如慢性阻塞性肺病、神经肌肉疾病和肥胖通气不足综合症)的患者可能需要长期机械通气支持。家庭通气计划为这些患者提供了解决方案,并延长了呼吸器的使用范围。家用人工呼吸器的设计考虑了患者的舒适度。家庭通气计划通常包含远端医疗,使患者能够远端获得专家咨询。这对于偏远和服务欠缺地区的患者尤其重要。家庭通风计画的扩大一直是推动市场成长的关键因素。
市场抑制因素
支援链中断阻碍及时生产和供应
支援链中断使製造商难以及时生产并向医疗机构交付人工呼吸器。需求增加和支援链中断可能会延迟向有需要的患者提供救生设备。供不应求推高了机械人工呼吸器的价格,使医疗机构难以负担得起,特别是在资源有限的环境中。成本上升使医疗保健提供者的预算紧张。在某些情况下,支援链中断可能会加快人工呼吸器的采购速度并损害所购买设备的品质。资源分配决策对临床医师来说是一种精神负担。支援链中断可能会导致物流挑战,包括将人工呼吸器运送到医疗机构的延误以及有效储存和分配的困难。因此,阻碍及时生产和交付的支援链中断可能会减缓市场成长。
按模式分類的展望
依模式划分,市场分为侵入性通气和非侵入性通气。 2022 年,有创通气细分市场收益占有率最大。侵入性通气用于各种临床应用,包括 ICU、手术室、急诊室和术后恢復。这种多功能性确保了对侵入性人工呼吸器的稳定需求。有创人工呼吸器配备先进的监测和警报系统,确保病人安全。这包括追踪气道压力、潮气量和氧气浓度等参数。有创通气对于遭受创伤、濒临溺水或正在经历其他危及生命的紧急情况的患者至关重要。这些患者可能需要立即插管和机械通气。
组件展望
按组件划分,市场分为设备和服务。 2022 年,服务业在市场中获得了显着的收益占有率。医疗机构通常需要专业协助来正确安装和设置机械人工呼吸器。当医护人员遇到人工呼吸器问题时,技术支援和服务台服务可以及时提供协助。这种支持可以快速解决问题并最大限度地减少对患者照护的干扰。一些服务供应商提供远端监控和故障排除功能,使您可以远端存取人工呼吸器并诊断问题。这减少了现场服务联络人的数量并加快了问题的解决速度。
产品类型展望
按产品类型划分,市场分为加护病房/重症患者、运输/便携式/门诊和新生儿。 2022年,加护病房/重症患者监护细分市场占市场最高销售占有率。在加护病房/重症患者护理领域,机械人工呼吸器用于多种情况,包括呼吸衰竭、创伤、感染疾病和手术恢復。 ICU 经常管理患有慢性呼吸道疾病(例如慢性阻塞性肺病)的患者,这些患者在急性发作期间可能需要机械通气支持。这种类型的慢性护理有助于加护病房/重症加护领域的持续需求。
年龄组展望
按年龄组别划分,市场分为成人、老年人和儿童/新生儿。在 2022 年的市场中,老年人细分市场占据了重要的收益占有率。老年人更容易罹患与老龄化相关的呼吸道疾病,如慢性阻塞性肺病、肺炎和阻塞型睡眠呼吸中止症。老年患者通常患有多种合併症,这可能会使呼吸系统疾病复杂化并增加机械通气的需求。常见的合併症包括心臟病、糖尿病和神经病变。许多老年人需要针对各种情况进行手术干预,包括心血管手术和髋置换术。老年患者在术后恢復期间可能需要机械通气,增加了对人工呼吸器的需求。
最终用户前景
依最终用户划分,市场分为医院/诊所、门诊手术中心、居家医疗等。 2022年,医院和诊所细分市场以最高的收益占有率引领市场。医院和诊所部门是慢性呼吸道疾病患者管理的核心。机械人工呼吸器对于神经肌肉疾病和严重气喘患者至关重要。医院和诊所经常使用运输人工呼吸器在病房、部门和医疗机构之间安全地转移患者,同时保持足够的通风。医院经常提供家庭通气服务,将机械人工呼吸器的使用扩展到病人家中。这包括为患者及其看护者提供便携式通气设备和培训。
区域展望
从区域来看,我们对北美、欧洲、亚太地区和拉丁美洲地区的市场进行了分析。 2022年,北美地区以最高的收益占有率引领市场。北美,特别是美国和加拿大,人口正在迅速高龄化。老年人更容易患呼吸道疾病,并且可能需要人工呼吸来治疗各种疾病。北美慢性阻塞性肺病和气喘等慢性呼吸道疾病的盛行率很高。机械人工呼吸器对于这些疾病的治疗至关重要,尤其是在病情恶化期间。
The Global Mechanical Ventilators Market size is expected to reach $16.7 billion by 2030, rising at a market growth of 12.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,039.4 thousand units, experiencing a growth of 27.4% (2019-2022).
As per the World Health Organisation, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. Mechanical ventilators are essential for managing these age-related respiratory issues. Consequently, the Geriatric segment captured $2,172.9 million revenue in the market in 2022. It plays a vital role in enhancing the quality of life for older adults by providing advanced respiratory support tailored to their physiological nuances. The elderly population is susceptible to respiratory complications due to weakened respiratory muscles, decreased lung function, and comorbidities.
The major strategies followed by the market participants are Partnerships, Collaborations & Agreements as the key developmental strategy to keep pace with the changing demands of end users. For instance, In June, 2023, Koninklijke Philips N.V. collaborated with Biotronik, aimed to widen the range of cardiovascular devices available for Philips SymphonySuite customers. Additionally, ZOLL Medical Corporation teamed up with Cogmedix, aimed to boost the production of ventilators during the COVID-19 pandemic.
Based on the Analysis presented in the KBV Cardinal matrix; Medtronic PLC is the forerunners in the Market. For Instance, In April, 2022, Medtronic PLC collaborated with GE Healthcare focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Under this collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service. Companies such as General Electric (GE) Co., Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA are some of the key innovators in Market.
COVID-19 Impact Analysis
The most immediate and visible impact of COVID-19 on the market was the unprecedented surge in demand for these life-saving devices. As the virus rapidly spread and overwhelmed healthcare systems in various countries, there was a significant shortage of ventilators to support critically ill patients. Hospitals and healthcare facilities faced an acute need to increase their ventilator capacity to manage the influx of COVID-19 patients. COVID-19 accelerated the adoption of remote monitoring and telehealth solutions, including integrating ventilators into telemedicine networks. These designs focused on essential functions to address the surge in demand, even if they lacked some of the advanced features of traditional ventilators. While these innovations provided short-term relief, they also raised concerns about the quality and safety of rapidly developed devices. Thus, the COVID-19 pandemic had a positive effect on the market.
Market Growth Factors
Rising prevalence of respiratory diseases
Respiratory diseases such as COPD, asthma, and interstitial lung diseases are highly prevalent, particularly in aging populations. These conditions often require long-term or intermittent ventilatory support, creating a sustained demand for mechanical ventilators. Various chronic conditions, such as heart failure and neuromuscular disorders, can result in respiratory complications that require mechanical ventilation for optimal patient care. The co-occurrence of these conditions adds to the demand for ventilators. The prevalence of pediatric and neonatal respiratory disorders, such as respiratory distress syndrome and bronchiolitis, necessitates specialized neonatal and pediatric ventilators. The prevalence of respiratory diseases has driven the integration of mechanical ventilators with telemedicine networks and remote monitoring technologies. This permits healthcare providers to remotely monitor patients with respiratory conditions and adjust ventilator settings, improving access to care. The rising prevalence of respiratory diseases is a significant driver of growth in the market.
Expansion of home ventilation programs
Home ventilation programs create a growing demand for mechanical ventilators in home settings. These ventilators are often more compact, user-friendly, and easy to operate, making them suitable for patients and caregivers. Patients with chronic respiratory conditions, such as COPD, neuromuscular disorders, and obesity hypoventilation syndrome, may require long-term ventilatory support. Home ventilation programs provide a solution for these patients, extending the use of ventilators. Home ventilators are designed with a focus on patient comfort. Telemedicine is frequently integrated into home ventilation programs, allowing patients to access specialist consultations remotely. This is especially important for patients in remote or underserved areas. The expansion of home ventilation programs has been a pivotal factor in driving the growth of the market.
Market Restraining Factors
Supply chain disruptions hampering timely production and delivery
Supply chain disruptions can make it challenging for manufacturers to produce and deliver ventilators to healthcare facilities in a timely manner. Increased demand and supply chain disruptions can delay the provision of life-saving equipment to needy patients. Shortages can drive up the prices of mechanical ventilators, making them less affordable for healthcare facilities, especially in resource-constrained settings. Higher costs can strain the budgets of healthcare providers. In some cases, supply chain disruptions can lead to a rush to procure ventilators, potentially compromising the quality of devices purchased. Decisions about resource allocation can be emotionally taxing for clinicians. The disruption of the supply chain can result in logistical challenges, including delays in transporting ventilators to healthcare facilities and difficulties in storing and distributing them effectively. Thus, supply chain disruptions hampering timely production and delivery can slow down the growth of the market.
Mode Outlook
Based on mode, the market is divided into invasive ventilation and non-invasive ventilation. In 2022, the invasive ventilation segment registered the maximum revenue share in the market. Invasive ventilation is utilized across various clinical applications, including ICUs, operating rooms, emergency departments, and post-operative recovery. This versatility ensures consistent demand for invasive ventilators. Invasive ventilators are equipped with advanced monitoring and alarm systems to ensure patient safety. This includes tracking parameters such as airway pressure, tidal volume, and oxygen levels. Invasive ventilation is crucial for patients who have suffered traumatic injuries, near-drowning incidents, or other life-threatening emergencies. These patients may require immediate intubation and mechanical ventilation.
Component Outlook
On the basis of component, the market is bifurcated into devices and services. The services segment garnered a significant revenue share in the market in 2022. Healthcare facilities often require professional assistance for the proper installation and setup of mechanical ventilators. Technical support and help desk services provide timely assistance to healthcare providers when they encounter issues with ventilators. This support ensures quick problem resolution and minimizes disruptions in patient care. Some service providers offer remote monitoring and troubleshooting capabilities, allowing them to access ventilators and diagnose issues from a distance. This can decrease the number of on-site service contacts and expedite the resolution of issues.
Product Type Outlook
By product type, the market is categorized into intensive care unit/critical care, transport/portable/ambulatory, and neonatal care. In 2022, the intensive care unit/critical care segment held the highest revenue share in the market. The intensive care unit/critical care segment utilizes mechanical ventilators for a wide range of conditions, including respiratory failure, trauma, infections, surgery recovery, and more. ICUs often manage patients with chronic respiratory conditions, such as COPD, who may require ventilatory support during acute exacerbations. This chronic care aspect contributes to sustained demand in the intensive care unit /critical care segment.
Age Group Outlook
Based on age group, the market is classified into adult, geriatric, and pediatric & neonatal. The geriatric segment acquired a substantial revenue share in the market in 2022. Elderly individuals are more prone to age-related respiratory conditions, such as COPD, pneumonia, and obstructive sleep apnea. Geriatric patients often have multiple comorbidities, which can complicate respiratory conditions and lead to a greater need for mechanical ventilation. Common comorbidities include heart disease, diabetes, and neurological disorders. Many elderly individuals require surgical interventions for various medical conditions, such as heart surgery or hip replacement. Post-surgical mechanical ventilation may be necessary for geriatric patients during their recovery, contributing to the demand for ventilators.
End User Outlook
By end user, the market is fragmented into hospital & clinic, ambulatory surgical center, home care, and others. In 2022, the hospital & clinic segment led the market by generating highest revenue share. Hospitals & clinics segment are central in managing patients with chronic respiratory conditions. Mechanical ventilators are essential for patients with neuromuscular disorders or severe asthma. Hospitals & clinics often use transport ventilators to safely transfer patients between units, departments, or healthcare facilities while maintaining proper ventilation. Hospitals often provide home ventilation services, extending the use of mechanical ventilators into patients' homes. This includes the provision of portable ventilators and training for patients and their caregivers.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America, particularly the United States and Canada, has a rapidly aging population. The elderly are more susceptible to respiratory illnesses and may require mechanical ventilation for various medical conditions. North America has a high prevalence of chronic respiratory diseases such as COPD and asthma. Mechanical ventilators are essential for managing these conditions, especially during exacerbations.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Medtronic PLC, Dragerwerk AG & Co. KGaA, Getinge AB, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Carl Reiner GmbH, Mindray Medical International Limited and Vyaire Medical, Inc.
Recent Strategies Deployed in Mechanical Ventilators Market
Partnerships, Collaborations & Agreements:
Oct-2023: Mindray Medical International Limited announced a partnership with Edwards Lifesciences, a global leader in medical innovations. This collaboration made Mindray's BeneVision N-Series the initial patient monitoring system to integrate with Edwards FloTrac sensor for hemodynamic monitoring in the North American market, after their joint launch in China in 2022.
Sep-2023: Medtronic Canada ULC, a subsidiary of Medtronic PLC, partnered with FluidAI Medical, a notable AI startup. Their collaboration aimed to revolutionize Canadian healthcare through the Continuous Connected Patient Care (CCPC) project under Canada's DIGITAL Global Innovation Cluster for digital technologies.
Jul-2023: Mindray Medical International Limited and SingHealth signed a memorandum of understanding aimed at delivering high-quality, accessible patient care. The partnership focused on medical training, academic platform development, and facilitating international exchanges on clinical topics. This collaboration aims to promote knowledge sharing and advance global healthcare.
Jun-2023: Koninklijke Philips N.V. collaborated with Biotronik, a multi-national cardiovascular biomedical research and technology company. This collaboration aimed to widen the range of cardiovascular devices available for Philips SymphonySuite customers.
May-2023: Mindray Medical International Limited signed a strategic agreement with Vithas, a GMP-certified chemical analysis contract lab, allowing Vithas to integrate innovative patient monitoring technology in its 20 hospitals. The partnership aimed to enhance patient safety in critical areas, including the ICU, post-anesthesia recovery, operating rooms, and emergencies.
Apr-2022: Medtronic PLC collaborated with GE Healthcare focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Under this new collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service.
Mar-2022: Asahi Kasei Corporation has teamed up with Genomatica, Inc., a company specializing in biological manufacturing processes for chemicals. Their collaboration is focused on bringing renewable nylon 6,61, created from Genomatica's bio-based HMD building block, to market. This partnership also aligns with Asahi Kasei's goal to be a pioneer in offering eco-friendly nylon 6,6 for the automotive and electronics sectors using plant-based HMD, thereby advancing their sustainability objectives.
Jan-2021: Drager Distribution extended its agreement with Breas Medical. Through this agreement, the companies aimed to supply LTACs and SNFspproch with comprehensive ventilation solutions, cost-effective, designed to improve patient health.
Nov-2020: ZOLL Medical Corporation, a medical devices manufacturer and a member of Asahi Kasei Corporation, teamed up with Cogmedix, provides FDA and ISO 13485 compliant product development and commercialization services. The companies aimed to boost the production of ventilators during the COVID-19 pandemic.
Jun-2020: Medtronic PLC formed a partnership with Foxconn, a multinational electronics contract manufacturer. The companies aimed to enlarge ventilator supply for more patients and hospitals than any other company can do individually.
May-2020: Vyaire Medical collaborated with Spirit AeroSystems, the world's largest manufacturers of aerostructures. Together, the companies aimed to construct critical care ventilators at a transformed space in Wichita, Kan. Moreover, this partnership would permit Vyaire to ramp up rapidly in the production of critical care ventilators.
Apr-2020: GE Healthcare teamed up with Microsoft, an American multinational technology corporation. Together, the companies aimed to launch a new software solution, Mural Virtual Care Solution. This software would give a wide view of the crowd around their ventilated patient and the risk of deterioration.
Apr-2020: Philips formed a partnership with Flex as well as Jabil. The partnership aimed to fast-track the production of ventilators and boost overall supply.
Apr-2020: Royal Philips collaborated with the U.S. Government. The entities aimed to enlarge the production of hospital ventilators, manufacturing in the U.S to save lives all around.
Apr-2020: Vyaire Medical came into a contract of $407 million with Health and Human Services. The companies aimed to construct 22,000 ventilators in the coronavirus pandemic. The entities aimed to increase the production and ramp up the delivery of essential medical equipment required.
Apr-2020: Vyaire Medical received a contract of USD $50 million with the Brazilian Ministry of Health. The companies aimed to construct 4,300 iX5 ventilators during the pandemic. The entities aimed to ramp up manufacturing capacity across the globe to ensure a sufficient supply of ventilators and associated consumables at this crucial time.
Mar-2020: GE Healthcare joined hands with Ford Motor Company, an American multinational automobile manufacturer. The companies focused on growing up the production of ventilators and medical equipment to cure COVID-19 respiratory illness patients.
Mar-2020: Dragerwerk formed a partnership with Babock, international aerospace, defense, and Security Company. This partnership aimed to help in the development of ventilators for the ITV News and NHS.
Product Launches and Expansions:
Jan-2023: Getinge AB launched the Servo-C mechanical ventilator, offering lung-protective tools for pediatric and adult patients in selected markets. With modular components for smart fleet management, the launch aimed to enhance global healthcare accessibility and affordability. Features included CO2 monitoring and a servo compass for visualizing volume and pressure targets.
Mar-2022: ZOLL Medical Corporation, a subsidiary of Asahi Kasei, introduced the ZOLL Arrhythmia Management System (AMS). The system incorporated biometric data with traditional MCT devices, enhancing ECG information. A recent study affirmed that ZOLL AMS assists physicians in creating more informed patient treatment plans.
Oct-2021: Drager introduced the new Savina 300 NIV. This product aimed for consistent and secure non-invasive mechanical ventilation in both acute and chronic care facilities.
Jul-2021: Mindray Medical International Limited launched its new turbine-based ventilator, the SV300 Pro. The product is easy to configure, simple to operate, and flexible in use. Moreover, it provides a comfortable and overall cure for all types of patients with different ventilation modes.
Jun-2020: Royal Philips introduced its mobile Intensive Care Units for India. The product would support the critical-care requirements of patients. Moreover, each pre-fabricated ICU has a space of nine beds which will be produced by Philips in India.
Mergers & Acquisition:
Apr-2021: Dragerwerk took over most of the share from STIMIT, a MedTech company that reinvents intensive care by empowering patients to breathe. This technology aimed to increase the company's expertise in the field of lung-protective ventilation.
Geographical Expansions:
Jan-2022: Getinge expanded its geographical footprints in Wayne, New Jersey by establishing a new Experience Center. The company aimed to utilize healthcare leaders with immense experience and their technologies. In addition to displaying how solutions enlarge efficiencies and amplify the patient experience.
May-2020: Hamilton Medical expanded its global reach in critical care ventilators near the U.S. offices in Reno, Nevada. Through this expansion, the company aimed to supply new production facilities and more life-saving machines to the U.S.
Trials & Approvals:
Jul-2023: Getinge AB obtained US FDA clearance for Servo-air Lite, a wall gas-independent non-invasive mechanical ventilator. This expanded the company's market reach in the US, enabling it to target the non-invasive hospital segment with its ventilation offering.
Market Segments covered in the Report:
By Mode (Volume, Thousand Unit, USD Billion, 2019-30)
By Component (Volume, Thousand Unit, USD Billion, 2019-30)
By Product Type (Volume, Thousand Unit, USD Billion, 2019-30)
By Age Group (Volume, Thousand Unit, USD Billion, 2019-30)
By End User (Volume, Thousand Unit, USD Billion, 2019-30)
By Geography (Volume, Thousand Unit, USD Billion, 2019-30)
Companies Profiled
Unique Offerings from KBV Research